PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People\'s Republic of China.\', \'Department of Infectious Diseases, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, People\'s Republic of China.\', \'National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People\'s Republic of China.\', \'Key Laboratory of Medical Molecular Virology (MOE/MOH) Shanghai Medical College, Fudan University, Shanghai, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2022.2025746
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 35034582
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all